SCH-900776 5 mg | ≥98% LKT Laboratories, Inc. CHK1 inhibitor. More Information Supplier Page × SCH-900776
SCH-900776 1 mg | ≥98% LKT Laboratories, Inc. CHK1 inhibitor. More Information Supplier Page × SCH-900776
AZD-1208 10 mg | ≥98% LKT Laboratories, Inc. Pim-1 inhibitor. More Information Supplier Page × AZD-1208
AZD-1208 5 mg | ≥98% LKT Laboratories, Inc. Pim-1 inhibitor. More Information Supplier Page × AZD-1208
ABT-263 5 mg | ≥98% LKT Laboratories, Inc. BH3 mimetic; Bcl-2 and Bcl-xl inhibitor. More Information Supplier Page × ABT-263
ABT-263 5 mg | ≥98% LKT Laboratories, Inc. BH3 mimetic; Bcl-2 and Bcl-xl inhibitor. More Information Supplier Page × ABT-263
ABT-263 10 mg | ≥98% LKT Laboratories, Inc. BH3 mimetic; Bcl-2 and Bcl-xl inhibitor. More Information Supplier Page × ABT-263
IPI-145 5 mg | ≥98% LKT Laboratories, Inc. p110δ PI3K inhibitor. More Information Supplier Page × IPI-145
IPI-145 500 µg | ≥98% LKT Laboratories, Inc. p110δ PI3K inhibitor. More Information Supplier Page × IPI-145
